Abstract:Pseudomonas aeruginosa is a highly problematic opportunistic pathogen that causes a range of different infections. Infections are commonly treated with β-lactam antibiotics, including cephalosporins, monobactams, penicillins, and carbapenems, with carbapenems regarded as antibiotics of last resort. Isolates of P. aeruginosa can contain horizontally acquired bla genes encoding β-lactamase enzymes, but the extent to which these contribute to β-lactam resistance in this species has not been systematically quantified. The overall aim of this research was to address this knowledge gap by quantifying the frequency of β-lactamase-encoding genes in P. aeruginosa and by determining the effects of β-lactamases on susceptibility of P. aeruginosa to β-lactams. Genome analysis showed that β-lactamase-encoding genes are present in 3% of P. aeruginosa but are enriched in carbapenem-resistant isolates (35%). To determine the substrate antibiotics, 10 β-lactamases were expressed from an integrative plasmid in the chromosome of P. aeruginosa reference strain PAO1. The β-lactamases reduced susceptibility to a variety of clinically used antibiotics, including carbapenems (meropenem, imipenem), penicillins (ticarcillin, piperacillin), cephalosporins (ceftazidime, cefepime), and a monobactam (aztreonam). Different enzymes acted on different β-lactams. β-lactamases encoded by the genomes of P. aeruginosa clinical isolates had similar effects to the enzymes expressed in strain PAO1. Genome engineering was used to delete β-lactamase-encoding genes from three carbapenem-resistant clinical isolates and increased susceptibility to substrate β-lactams. Our findings demonstrate that acquired β-lactamases play an important role in β-lactam resistance in P. aeruginosa, identifying substrate antibiotics for a range of enzymes and quantifying their contributions to resistance.IMPORTANCEPseudomonas aeruginosa is an extremely problematic pathogen, with isolates that are resistant to the carbapenem class of β-lactam antibiotics being in critical need of new therapies. Genes encoding β-lactamase enzymes that degrade β-lactam antibiotics can be present in P. aeruginosa, including carbapenem-resistant isolates. Here, we show that β-lactamase genes are over-represented in carbapenem-resistant isolates, indicating their key role in resistance. We also show that different β-lactamases alter susceptibility of P. aeruginosa to different β-lactam antibiotics and quantify the effects of selected enzymes on β-lactam susceptibility. This research significantly advances the understanding of the contributions of acquired β-lactamases to antibiotic resistance, including carbapenem resistance, in P. aeruginosa and by implication in other species. It has potential to expedite development of methods that use whole genome sequencing of infecting bacteria to inform antibiotic treatment, allowing more effective use of antibiotics, and facilitate the development of new antibiotics.

The induced expression of AmpC gene in pseudomonas aeruginosa biofilms

Expression of β-Lactamase in Pseudomonas aeruginosa Biofilms

Effect of Quorum Sensing Systems in Pseudomonas Aeruginosa Biofilms on Expression of AmpC Gene

The Role of Quorum Sensing System in Antimicrobial Induced Ampc Expression in Pseudomonas Aeruginosa Biofilm

Quorum Sensing Systems in Pseudomonas Aeruginosa in Regulating Formation of Biofilms and Expression of AmpC Gene

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance

Expression of Multi-Drug Efflux Pump Gene in Pseudomonas Aeruginosa Biofilms.

High Β-Lactamase Levels Change the Pharmacodynamics of Β-Lactam Antibiotics in Pseudomonas Aeruginosa Biofilms.

Ampg Gene Of Pseudomonas Aeruginosa And Its Role In Beta-Lactamase Expression

The Status of Drug Resistance and Ampc Gene Expression in Enterobacter Cloacae

Effects of ampC gene distribution and AmpC enzyme production in Pseudomonas aeruginosa on drug susceptibility

[The Effect of Biofilms on the Production of Beta-Lactamases in Pseudomonas Aeruginosa].

Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam

Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β-lactam antibiotic resistance

Expression of adeB mRNA in imipenem induced carbapenem resistant Acinetobacter baumannii clinical isolates

Relationship between antimicrobial susceptibility and highly active β-lactamases in Pseudomonas aeruginosa

Extended-spectrum Beta-lactamases and AmpC Enzymes of Pseudomonas Aeruginosa in Lower Respiratory Tracts: Their Detection and Significance

Transcriptomics Study on Staphylococcus Aureus Biofilm under Low Concentration of Ampicillin

Protective effects of antibiotic resistant bacteria on susceptibles in biofilm: Influential factors, mechanism, and modeling

AmpC induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem/relebactam susceptibility

Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance